Article Text
Miscellaneous
Budesonide/formoterol may be used for adjustable maintenance dosing in asthma
Statistics from Altmetric.com
This randomised, double blind/open two phase multicentre study, sponsored by Astra Zeneca, was conducted over 7 months to find out if asthma control was better when patients adjusted the maintenance dose of inhaled budesonide/formoterol (Symbicort Turbohaler) according to asthma symptoms than when fixed dose (FD) regimens were used.
Eligible patients were randomised to one of three groups: (1) Symbicort …